CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Recruiting
N/A
Interventional Study
Chronic Kidney Disease Stage 5
End Stage Renal Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 340 (estimated)
- Sponsor
- University of Manitoba · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \>18 years of age
* Patient or primary caregiver can read and speak English
* Patient or patients substitute decision maker is able to provide informed consent
* Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application a…
Contacts